-
InterMune Divests Danoprevir
Thursday, October 7, 2010 - 10:10am | 157Read More...InterMune Inc. (NASDAQ: ITMN) after the market close yesterday announced they monetized its lead HCV asset danoprevir by selling the worldwide development and commercialization rights to Roche for $175M in cash. In a research note, J.P.Morgan writes, "In our view, this is an important step for the...
-
Costco Remains Overweight
Wednesday, October 6, 2010 - 11:54am | 134Read More...Costco Wholesale Corporation (NASDAQ: COST) printed 4Q EPS of $0.97, $.$04 above estimates while reporting an below September comp core SSS estimate of 3.5% vs 4.0%. In a research report, J.P.Morgan writes, "Costco reported 4Q EPS of $0.97, $0.04 ahead of our estimate and $0.02 north of the Street...
-
Costco Remains Overweight
Wednesday, October 6, 2010 - 11:34am | 134Read More...Costco Wholesale Corporation (NASDAQ: COST) printed 4Q EPS of $0.97, $.$04 above estimates while reporting an below September comp core SSS estimate of 3.5% vs 4.0%. In a research report, J.P.Morgan writes, "Costco reported 4Q EPS of $0.97, $0.04 ahead of our estimate and $0.02 north of the Street...
-
Enough Is Enough. IR Too Cheap Again. Time To Buy.
Monday, October 4, 2010 - 12:43pm | 110Read More...Ingersoll-Rand (NYSE: IR) is a top pick by J.P.Morgan. The stock is trading at a tremendous discount to competitors and has a large upside potential. In a research note, J.P Morgan writes, "IR is once again a top pick in our group as the stock continues to lag on concerns that we think are...
-
Lowering Estimates On HOLX
Monday, October 4, 2010 - 12:21pm | 90Read More...Hologic, Inc. (NASDAQ: HOLX) despite encouraging signs for the Breast Health business J.P Morgan believes consensus numbers remain high. In a research note, J.P.Morgan writes, "We believe that 2011 consensus numbers remain high, due to the volume-dependent Cytyc businesses and the likelihood of...
-
Overweight Rating Set On Aspen Technology
Monday, October 4, 2010 - 11:56am | 116Read More...Aspen Technology, Inc. (NASDAQ: AZPN) shares are currently trading 35% below J.P Morgan's initial December price target of $15.00. In a research report J.P.Morgan writes, "We are initiating coverage of Aspen Technology with an Overweight rating and Dec-11 $15 price target. Two years of financial...
-
J.P. Morgan Increases Price Target On Westar Energy Inc
Monday, October 4, 2010 - 11:13am | 125Read More...Westar Energy, Inc. (NYSE: WR) getting ready to look past 2011, but waiting for more clarity. In a research note, J.P.Morgan writes,"We are updating our investment opinion on Westar Energy and establishing a December 2011 price target of $25 per share. We expect Westar to continue to benefit from...
-
Sealy Corp FQ3 Results Were Disappointing
Wednesday, September 29, 2010 - 1:08pm | 76Read More...Sealy Corp. (NYSE: ZZ) FQ3 results were disappointing as the company's EPS was .01 below estimate. In a research report by J.P.Morgan "Aside from a difficult macro backdrop, company-specific issues (such as inability to effectively manage simultaneous launch of too many new products and delays in...
-
RIMM Announces Its' 7" Wi-Fi Only Tablet Device
Tuesday, September 28, 2010 - 9:01am | 111Read More...Research In Motion (NASDAQ: RIMM) announced their answer to the Ipad today with its release of the BlackBerry Tablet. In a research report J.P.Morgan writes "RIMM announced its 7" wi-fi only tablet device, the BlackBerry Playbook, running RIMM's new QNX tablet OS. The device is 9.7mm thick, has...
-
Hospira, Inc. Taxotere Ruling A Positive For Shareholders
Tuesday, September 28, 2010 - 8:47am | 107Read More...Delaware District Court ruling on the Taxotere patents is seen as a meaningful positive for Hospira, Inc. (NYSE: HSP) according to a J.P. Morgan research report. J.P.Morgan writes, "While we anticipate temporary restraining order/preliminary injunction requests from Sanofi, we believe this ruling...
-
J.P. Morgan Rates Gap Neutral, Sees No Upside (GPS)
Monday, August 23, 2010 - 8:23am | 193Read More...J.P.Morgan sees no upside in shares of Gap, Inc. (NYSE: GPS) after the company reported an inline quarter last week. It rates shares at Neutral and has a $17 price target. In a note to investors, J.P. Morgan writes, "We are introducing our Dec 2011 price target of $17 (which replaces prior Dec...
-
J.P.Morgan Highlights Recent Manager Meetings With Gartner Inc. (IT)
Thursday, August 19, 2010 - 2:45pm | 167Read More...J.P.Morgan is out with a report where it reiterates its “overweight” rating on Gartner Inc. (NYSE: IT); it also raised its target price on the stock to $35.00 from $30.00. Analysts think the company could see some profit taking in the short-term after shares jumped 9% last week. J.P.Morgan...
-
J.P.Morgan Trims Estimates And Reduces Price Target On Western Digital (WDC)
Tuesday, August 17, 2010 - 10:25am | 134Read More...J.P.Morgan is out with a report, where it maintains its “neutral” rating on shares of Western Digital Corporation (NYSE: WDC); it has also reduced its target price to $34.50 from $37.50. The analysts at J.P.Morgan are reducing their estimates based on a widening slowdown in consumer spending in...
-
J.P.Morgan Reiterates Overweight Rating On UDR, Inc. (UDR)
Tuesday, August 3, 2010 - 3:59pm | 203Read More...J.P.Morgan is out with a report, where it reiterates its “overweight” rating on shares of UDR, Inc. (UDR); it has set a price target at $19.00. Analysts noted, “UDR revised its 2010 guidance range to $1.07-$1.11/share from $1.00-$1.07/share. The midpoint of the revised range of $1.09/share is...
-
VeriSign Authorized New $1.1B Buyback (VRSN)
Tuesday, August 3, 2010 - 3:27pm | 171Read More...J.P.Morgan is out with a report on VeriSign (VRSN), after the company reported revenue and Non-GAAP EPS from continuing operations that beat out consensus and analyst estimates. VRSN repurchased 8.1M shares worth about $228M in the second quarter, and authorized another $1.1B in buybacks. One...

